MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) today announced that Mr. Jean-Luc Tétard, the President of the Stragen Group of companies, has joined the company’s Board of Directors effective immediately. Mr. Tétard is an experienced senior executive and director with more than 35 years’ experience in the pharmaceutical and biotechnology industries.
